2015, Número 3
<< Anterior
Rev Mex Cardiol 2015; 26 (3)
Pericarditis efusivo-constrictiva: revisión a propósito de un caso
Arceo-Navarro A, Harrison-Gómez C, Sánchez-Lezama F, Domínguez-Carrillo LG, Arredondo-Arzola V
Idioma: Ingles.
Referencias bibliográficas: 52
Paginas: 140-148
Archivo PDF: 269.60 Kb.
RESUMEN
Antecedentes: La pericarditis efusivo-constrictiva es un síndrome hemodinámico poco frecuente, en el cual el pericardio visceral constriñe al corazón con la presencia de líquido libre en el espacio pericárdico; fue descrito y caracterizado por Hancock en 1971. Se caracteriza por la presencia de presión elevada en la aurícula derecha persistente después de pericardiocentesis del derrame pericárdico; su etiología es diversa y su curso incierto, llegando a ser reversible o más frecuentemente requerir pericardiectomía extensa.
Caso clínico: Masculino de 35 años sin antecedentes de importancia, con evolución de disnea progresiva y dolor torácico secundarios a infección de vías aéreas, en quien se efectuó diagnóstico de derrame pericárdico, manejado con colchicina y AINEs, evolucionando con disminución del derrame pero empeorando las alteraciones hemodinámicas, corroboradas por ecocardiografía. Con diagnóstico de pericarditis efusivo-constrictiva fue sometido a pericardiectomía con excelente evolución, clasificando el cuadro como idiopático después de múltiples pruebas diagnósticas en busca de la etiología.
Conclusiones: La pericarditis efusivo-constrictiva es un síndrome poco frecuente que debe tenerse presente en la evolución de los pacientes con derrame pericárdico.
REFERENCIAS (EN ESTE ARTÍCULO)
Hancock EW. Subacute effusive-constrictive pericarditis. Circulation. 1971; 43: 183-192.
Santa Cruz RJ, Sahagún SG, González CD, Sánchez GN. Análisis de las características clínicas, ecocardiográficas, microbiológicas y citopatológicas de derrames pericárdicos en un hospital de tercer nivel de atención. Arch Cardiol Mex. 2014; 84: 86-91.
3- Sagrista SA, Merce J, Permanyer MG et al. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000; 109: 95-101.
4- Aguilar J, Summerson C, González E et al. Pericarditis tuberculosa Experiencia de 10 años. Arch Cardiol Mex. 2007; 77: 209-216.
5- Lind A, Reinsch N, Neuhaus K et al. Pericardial effusion of HIV-infected patients? Results of a prospective multicenter cohort study in the era of antiretroviral therapy. Eur J Med Res. 2011; 16: 480-483.
Pankuweit S, Ristic AD, Seferovic PM, Maisch B. Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs. 2005; 5: 103-112.
Ling LH, Oh JK, Schaff HV et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999; 100: 1380-1386.
Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci. 2009; 338: 211-216.
Corey G, Campbell P, van Trigt P et al. Etiology of large pericardial effusions. Am J Med. 1993; 95: 209-213.
Ben-Horin S, Bank I, Shinfeld A, Kachel E, Guetta V, Livneh A. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis. Am J Cardiol. 2007; 99: 1294-1297.
Maisch B, Seferovic P, Ristic A. Guidelines on the diagnosis and management of pericardial diseases executive summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2004; 25:587.
Hoit BD. Pericardial disease and pericardial tamponade. Crit Care Med. 2007; 35 Suppl: S355-364.
Permanyer-Miralda G, Sagristá-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol. 1985; 56: 623-630.
Nugue O, Millaire A, Porte H et al. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients. Circulation. 1996; 94: 1635-1641.
Sagrista-Sauleda J, Angel J, Permanyer-Miralda G. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999; 341: 2054-2059.
Tsang T, Enriquez-Sarano M, Freeman W et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: Clinical profile, practice patterns, and outcomes spanning 21 years. May Clin Proc. 2002; 77: 429-436.
Ramírez F, Sarmiento M, Orjuela T et al. Características clínicas y ecocardiográficas de los derrames pericárdicos en pacientes del Hospital Universitario de San Vicente de Paúl. IATREIA. 2002; 15: 135-142.
Beck C. Two cardiac compression triads. JAMA. 1935; 104: 714-716.
Cheema M, Ghalib M, Shatoor A et al. Pattern of pericardial disease in the Asir Region of Saudi Arabia. Ann Saudi Med. 2007; 19: 171-173.
Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Outcomes of clinically significant idiopathic pericardial effusion requiring intervention. Am J Cardiol. 2003; 91: 704-707.
Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004; 363: 717-727.
Little WC, Freeman GL. Pericardial disease. Circulation. 2006; 113: 1622-1632.
Meyers DG, Bagin RG, Levene JF. Electrocardiographic changes in pericardial effusion. Chest. 1993; 104: 1422-1426.
Eisenberg MJ, de Romeral LM, Heidenreich PA. The diagnosis of pericardial effusion and cardiac tamponade by 12-lead ECG. A technology assessment. Chest. 1996; 110: 318-324.
Bruch C, Schmermund A, Dagres N et al. Changes in QRS voltage in cardiac tamponade and pericardial effusion: reversibility after pericardiocentesis and after anti-inflammatory drug treatment. J Am Coll Cardiol. 2001; 38: 219-226.
Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003; 349: 684-690.
Pepi M, Muratori M. Echocardiography in the diagnosis and management of pericardial disease. J Cardiovasc Med. 2006; 7: 533-544.
Gandhi S, Schneider A, Mohiuddin S et al. Has the clinical presentation and clinician’s index of suspicion of cardiac tamponade changed over the past decade? Echocardiography. 2008; 25: 237-241.
Naqvi TZ, Huynh HK. A new window of opportunity in echocardiography. J Am Soc Echocardiogr. 2006; 19: 569-577.
Horowitz MS, Schultz CS, Stinson EB et al. Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation. 1974; 50: 239-247.
Karia DH, Xing YQ, Kuvin JT, Nesser HJ, Pandian NG. Recent role of imaging in the diagnosis of pericardial disease. Curr Cardiol Rep. 2002; 4: 33-40.
Restrepo CS, Lemos DF, Lemos JA, et al. Imaging findings in cardiac tamponade with emphasis on CT. Radiographics. 2007; 27: 1595-1610.
Eichler K, Zangos S, Thalhammer A et al. CT-guided pericardiocenteses: clinical profile, practice patterns and clinical outcome. Eur J Radiol. 2010; 75: 28-31.
Ben-Horin S, Bank I, Shinfeld A et al. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis. Am J Cardiol. 2007; 99: 1294-1297.
Kim SH, Kwak MH, Park S et al. Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat. 2010; 42: 210-216.
Aguilar JA, Summerson C, González ME et al. Pericarditis tuberculosa. Experiencia de 10 años Arch Cardiol Mex. 2007; 77: 209-216.
Refaat MM, Katz WE. Neoplastic pericardial effusion. Clin Cardiol. 2011; 34: 593-598.
Meurin P, Tabet JY, Thabut G et al. Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: a multicenter randomized, double-blind trial. Ann Intern Med. 2010; 152: 137-143.
Imazio M, Belli R, Brucato A et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP 2): a multicentre, double-blind, placebo-controlled, randomized trial. Lancet. 2014; DOI:10.1016/S0140-6736(13)62709-9.
Imazio M, Brucato A, Cumetti D et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008; 118 (6): 667-671.
Rosenbaum E, Krebs E, Cohen M et al. The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review. Lupus. 2009; 18: 608-612.
Maisch B, Ristic AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J. 2002; 23: 1503-1508.
Artom G, Koren-Morag N, Spodick DH et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J. 2005; 26: 23-727.
Allen KB, Faber LP, Warren WH. Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage. Ann Thorac Surg. 1999; 67: 437-440.
Nugue O, Millaire A, Porte H et al. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients. Circulation. 1996; 94: 1635-1641.
Spodick DH, Kumar S. Subacute constrictive pericarditis with cardiac tamponade. Dis Chest. 1968; 54: 62-66.
D’Cruz IA, Pallas CW, Heck A. Echocardiographic diagnosis of effusive-constrictive pericarditis due to staphylococcal pericarditis after cardiac surgery. South Med J. 1991; 84: 1375-1377.
Castañón GA, AmézquitaLJ, Velasco OE, Deseano EJ, León GM. Pericarditis constrictiva: historia de un corazón oprimido Cir Cir. 2010; 78: 342-346.
Walsh TJ, Baughman KL, Gardner TJ, Bulkley BH. Constrictive epicarditis as a cause of delayed or absent response to pericardiectomy: a clinicopathological study. J Thorac Cardiovasc Surg. 1982; 83: 126-132.
Cameron J, Oesterle SN, Baldwin JC, Hancock EW. The etiologic spectrum of constrictive pericarditis. Am Heart J. 1987; 113: 354-360.
Watanabe A, Hara Y, Hamada M et al. A case of effusive-constructive pericarditis: an efficacy of GD-DTPA enhanced magnetic resonance imaging to detect a pericardial thickening. Magn Reson Imaging. 1998; 16: 347-350.
Sagrista SJ, Permanyer MG, Candell RJ, Angel J et al. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am J Cardiol. 1987; 59: 961-966.